Migration of dendritic cell based cancer vaccines: in vivo veritas?
about
Therapeutic cancer vaccines and combination immunotherapies involving vaccinationTargeting MARCO can lead to enhanced dendritic cell motility and anti-melanoma activityDendritic cell-based human immunodeficiency virus vaccine.Human XCR1+ dendritic cells derived in vitro from CD34+ progenitors closely resemble blood dendritic cells, including their adjuvant responsiveness, contrary to monocyte-derived dendritic cells.Low molecular weight hyaluronan-pulsed human dendritic cells showed increased migration capacity and induced resistance to tumor chemoattraction.Optimized dendritic cell-based immunotherapy for melanoma: the TriMix-formula.Magnetovaccination as a novel method to assess and quantify dendritic cell tumor antigen capture and delivery to lymph nodes.Lentiviral vectors for induction of self-differentiation and conditional ablation of dendritic cells.In vivo migration of dendritic cells labeled with synthetic superparamagnetic iron oxideAn effective cancer vaccine modality: lentiviral modification of dendritic cells expressing multiple cancer-specific antigensImmunization of NSCLC patients with antigen-pulsed immature autologous dendritic cellsDendritic cells: tools and targets for antitumor vaccination.Tumor-associated antigens in breast cancer.DC-based cancer vaccines.A novel dendritic cell targeting HPV16 E7 synthetic vaccine in combination with PD-L1 blockade elicits therapeutic antitumor immunity in mice.Dendritic cell-based therapeutic cancer vaccines: what we have and what we need.Dendritic cells in immunotherapy of established cancer: Roles of signals 1, 2, 3 and 4Gene therapy targeting nuclear factor-kappaB: towards clinical application in inflammatory diseases and cancer.The evolving role of dendritic cells in cancer therapy.Polarized dendritic cells as cancer vaccines: directing effector-type T cells to tumors.Directing dendritic cell immunotherapy towards successful cancer treatment.Disarming dendritic cells: a tumor strategy to escape from immune control?Chemokines: can effector cells be redirected to the site of the tumor?Dendritic cell vaccines in cancer immunotherapy: from biology to translational medicine.Biological applications of magnetic nanoparticles.Cancer immunotherapy: a paradigm shift for prostate cancer treatment.Tracking and evaluation of dendritic cell migration by cellular magnetic resonance imaging.Molecular insights into the development of T cell-based immunotherapy for prostate cancer.The development of dendritic cell vaccine-based immunotherapies for glioblastoma.Resistance to the proapoptotic effects of interferon-gamma on melanoma cells used in patient-specific dendritic cell immunotherapy is associated with improved overall survival.Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?"In situ" vaccination for systemic effects in follicular lymphoma.Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration.Cellular MRI as a suitable, sensitive non-invasive modality for correlating in vivo migratory efficiencies of different dendritic cell populations with subsequent immunological outcomes.Low molecular weight hyaluronan preconditioning of tumor-pulsed dendritic cells increases their migratory ability and induces immunity against murine colorectal carcinoma.Image-guided dendritic cell-based vaccine immunotherapy in murine carcinoma models.Labelling dendritic cells with SPIO has implications for their subsequent in vivo migration as assessed with cellular MRI.High-Dimensional Phenotypic Mapping of Human Dendritic Cells Reveals Interindividual Variation and Tissue Specialization.How effective could laser-based approaches be in assisting dendritic cell immunotherapy?Tumor Immuno-Environment in Cancer Progression and Therapy.
P2860
Q28397609-5E855746-1EFD-480D-A3BA-3FF673804E59Q33819701-B056EE5B-A2B5-441B-9976-77F1261657C4Q33874652-28B1A0D1-D70F-4734-9B5A-8BD37B5FB0CAQ33998442-EA702912-93ED-4A6B-A191-19587FB9FF05Q34216061-52F57DC5-B5C2-44EE-8672-15574A2D7A64Q34422110-A17269E0-802F-4224-A99F-C03994872D56Q34544058-09BB7512-0BB2-4A2E-988A-FFC037379157Q35161543-B5097C3C-921C-4F2D-AF22-2228436F51B1Q35556913-2BEEA0A4-C20B-41BD-9F2B-F10060CC6F51Q35747229-D41EDA4D-0C37-455C-9DEC-19CF9E8FCF1DQ36116566-EC98586D-F489-4F2C-B956-CC69688BA01AQ36284556-55694EE3-7F84-4D3D-802C-24C9314D4682Q36449259-B44CEF31-FA33-4342-A942-7703223D6640Q36809780-88B0481F-ED2F-45F9-B0CE-37D2B1A8ED43Q37079131-D9535096-9215-462E-8F23-21BC040C1B6EQ37448957-C01ABD78-EB1F-41C6-A8CC-033CAA9CCFD4Q37513871-C96BE986-6550-4564-930B-A41DBBA198D2Q37515656-67392F6E-6ADE-46EF-A936-D6D5F0F54512Q37687418-AA0E04E0-0A16-4A4D-98A7-4F612A4D0BEEQ37735454-18D492FE-8BBD-40B6-8AAB-3810CF922A00Q37754014-2E874F26-D142-435C-B093-A3F3397F651CQ37755322-8572CDDE-3420-419D-9AED-8505C6CEF797Q37778693-21836070-1954-4444-A21A-748FEBCD12B9Q37971324-FB8828F5-393C-4B3E-8721-1BB6F57C6C24Q38000520-FF86188A-04E0-4E5E-AAD5-2736C224D3A6Q38013964-661A6AE9-B2FB-45EC-B180-F0EFC2772131Q38103222-58AA253E-A967-4626-A43D-37F9D03ECE08Q38254639-4277D9B3-1195-4849-9EA6-B7447E7F6F40Q38990679-AA339F0B-4E13-4D43-B6ED-077937804AB2Q39642049-BF751A5F-933B-4A6C-A9CF-A7374F8845E8Q41520681-E4B91574-F9DC-45C9-8A44-16425B078252Q41593116-0FBCE20E-0599-47FE-992A-78F6CDD1D76AQ41968893-D896A83F-55C4-44A3-A38B-D3E3A689F841Q45305523-C4213C98-4A9D-4741-B33E-6C979B832433Q45870608-DA4B0A66-9DBC-43CA-9CCE-F0E2F6E55A27Q46195000-2BDC3BBC-FBEF-4B9C-BE88-93A0C4D4DF55Q46465072-054B8221-F491-43CA-9C38-C3E0118008F5Q47314216-8279636D-9FA4-4C05-AEFB-DEE4EFB981D3Q48356042-297C83AD-D374-4877-A624-8A2BEB148BCDQ49592937-D4AF23CC-1C30-4324-B896-9D7A581A5A1C
P2860
Migration of dendritic cell based cancer vaccines: in vivo veritas?
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Migration of dendritic cell based cancer vaccines: in vivo veritas?
@ast
Migration of dendritic cell based cancer vaccines: in vivo veritas?
@en
type
label
Migration of dendritic cell based cancer vaccines: in vivo veritas?
@ast
Migration of dendritic cell based cancer vaccines: in vivo veritas?
@en
prefLabel
Migration of dendritic cell based cancer vaccines: in vivo veritas?
@ast
Migration of dendritic cell based cancer vaccines: in vivo veritas?
@en
P2093
P1476
Migration of dendritic cell based cancer vaccines: in vivo veritas?
@en
P2093
Cornelis J A Punt
Gosse J Adema
I Jolanda M de Vries
P304
P356
10.1016/J.COI.2005.01.004
P50
P577
2005-04-01T00:00:00Z